Literature DB >> 17657053

Mycological and serological study of pulmonary aspergillosis in central India.

A M Kurhade1, J M Deshmukh, R P Fule, C Chande, S Akulwar.   

Abstract

PURPOSE: To study the prevalence and predisposing factors of Aspergillus infection and correlate microscopic, culture and serological findings along with drug sensitivity.
METHODS: Sputum samples from 123 patients of pulmonary disease with clinical suspicion of having fungal, especially Aspergillus infections, were examined microscopically and for culture. Minimum inhibitory concentration (MIC) of itraconazole was tested against the isolates. Serum samples from these patients were tested for precipitin against Aspergillus antigen using immunodiffusion (ID) technique.
RESULTS: Aspergillus species were isolated in 20 (16.26%) cases and Aspergillus fumigatus was the predominant species isolated in 16 (80%) cases. Precipitins were detected in 29 (23.58%) cases. Serum samples collected from 50 healthy individuals to serve as controls showed no precipitin against Aspergillus antigen galactomannan. This fungus was found to be sensitive to itraconazole with MIC range 0.125-1microg/mL.
CONCLUSIONS: Serological tests have an edge over routine smear and culture methods for the diagnosis of pulmonary aspergillosis. Itraconazole is more effective than amphotericin B and fluconazole in the treatment of aspergillosis.

Entities:  

Year:  2002        PMID: 17657053

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  10 in total

1.  Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis from Iran.

Authors:  M T Hedayati; Y Azimi; A Droudinia; B Mousavi; A Khalilian; N Hedayati; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-05-24       Impact factor: 3.267

2.  Fungal colonization in patients with chronic respiratory diseases from Himalayan region of India.

Authors:  Debasis Biswas; Sonal Agarwal; Girish Sindhwani; Jagdish Rawat
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-09-20       Impact factor: 3.944

3.  Clinico-microbiological profile of chronic pulmonary aspergillosis from a tertiary care centre in southern India.

Authors:  Kiran Chawla; Kranthi Kosaraju; Sridevi Rayasam; Chiranjay Mukhopadhyay
Journal:  J Clin Diagn Res       Date:  2013-12-15

4.  Estimation of the burden of chronic and allergic pulmonary aspergillosis in India.

Authors:  Ritesh Agarwal; David W Denning; Arunaloke Chakrabarti
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

5.  Aspergillus colonization in patients with chronic obstructive pulmonary disease.

Authors:  M Shahi; S A Ayatollahi Mousavi; M Nabili; M Aliyali; S Khodavaisy; H Badali
Journal:  Curr Med Mycol       Date:  2015-09

6.  Phenotypic profile of pulmonary aspergillosis and associated cellular immunity among people living with human immunodeficiency virus in Maiduguri, Nigeria.

Authors:  Idris Abdullahi Nasir; Halima Ali Shuwa; Anthony Uchenna Emeribe; Hafeez Aderinsayo Adekola; Amos Dangana
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2019 Jul-Sep

7.  Molecular Detection of Aspergillus in Sputum of Patients with Lower Respiratory Tract Infections.

Authors:  Alosha Sharma; Dakshina Bisht; Shukla Das; Gargi Rai; Shyama Dutt; V K Arora
Journal:  Int J Appl Basic Med Res       Date:  2020-04-02

8.  Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation.

Authors:  Iain D Page; Rosemary Byanyima; Sharath Hosmane; Nathan Onyachi; Cyprian Opira; Malcolm Richardson; Richard Sawyer; Anna Sharman; David W Denning
Journal:  Eur Respir J       Date:  2019-03-18       Impact factor: 16.671

9.  Tuberculosis Status and Coinfection of Pulmonary Fungal Infections in Patients Referred to Reference Laboratory of Health Centers Ghaemshahr City during 2007-2017.

Authors:  Mohammad Reza Jabbari Amiri; Rora Siami; Azad Khaledi
Journal:  Ethiop J Health Sci       Date:  2018-11

10.  Prevalence of invasive aspergillosis in suspected pulmonary tuberculosis at a referral tuberculosis hospital in Shandong, China.

Authors:  Jun-Li Wang; Xiao-Lin Zhou; Chao Han; Mao-Shui Wang; Hua Hu
Journal:  Epidemiol Infect       Date:  2020-11-05       Impact factor: 2.451

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.